CXCL13 and cancer: Compared with the expression levels in normal samples, ITLN1, TSPAN11, CPRC5B, and CXCL13 showed significantly low expression levels in most cancer types, including COAD (Fig. 13b–e), while TIMP1 was expressed highly in most cancer types (Fig. 13f).